Tianqing Chu

EGFR tyrosine kinase inhibitor (TKI) in patients with advanced non-small cell lung cancer (NSCLC) harboring uncommon EGFR mutations: A real-world study in China

Jianlin Xu, Bo Jin, Tianqing Chu et al. · Lung Cancer · 2016 · 94 citations

Oncology, Medicine, Pathology +8

NAD+ administration decreases doxorubicin-induced liver damage of mice by enhancing antioxidation capacity and decreasing DNA damage

Ban Wang, Yingxin Ma, Xiaoni Kong et al. · Chemico-Biological Interactions · 2014 · 54 citations

Dna Damage, Biochemistry, Medicine +13

Effective low-dose Anlotinib induces long-term tumor vascular normalization and improves anti-PD-1 therapy

Peng Fan, Huiping Qiang, Zhenhua Liu et al. · Frontiers in Immunology · 2022 · 34 citations · Full text

Prognostic value of tumor cavitation in extensive-stage small-cell lung cancer patients treated with anlotinib

Dongfang Chen, Jianlin Xu, Yizhuo Zhao et al. · Journal of Cancer Research and Clinical Oncology · 2019 · 26 citations · Full text

Tumor Cavitation, Medicine, Prognostic Value +8

Clinical characteristics and prognostic factors of surgically resected combined small cell lung cancer: a retrospective study

Yuqiong Lei, Hui Feng, Huiping Qiang et al. · Lung Cancer · 2020 · 25 citations

Retrospective Study, Prognostic Factors, Surgical Oncology +13